Cagrilintide Synonyms / Designations: Cagrilintide, AM833, Long-acting amylin analogue, Dual amylin receptor agonist CAS Number: 1415456-99-3 Molecular Formula: C194H312N54O59S2 Molecular Weight: 4409.01 g/mol Peptide Classification: Synthetic long-acting amylin analogue Purity: 99 % (HPLC, typical) Appearance: White to off-white lyophilised powder Pack Size: Research pack size (varies) Storage: Desiccated, protected from light, stored at 20 C Solubility: Soluble in sterile water and buffered aqueous solutions Description & Mechanism Cagrilintide is a synthetic long-acting analogue of the endogenous peptide hormone amylin, developed for experimental investigation of amylin receptor signalling and metabolic regulation
Unlike appetite suppressants or thermogenic stimulants, 5-Amino-1MQ targets metabolism at a cellular level
Key Takeaways: - Learn how cjc-1295 and ipamorelin work together - Typical Dosing and Protocol Structure - Understand what the research shows - Side Effects and Safety Considerations How CJC-1295 and Ipamorelin Work Together CJC-1295 and Ipamorelin both stimulate growth hormone release, but they do it through different mechanisms
Unlike many short signaling peptides that rapidly degrade in biological systems, BPC-157 exhibits relatively high structural stability and resistance to proteolytic breakdown
Provide Anti-inflammatory Effects: Studies show it can reduce pro-inflammatory cytokines like IL-6 and TNF-, which are key players in inflammatory skin conditions